Caspase 3 Inactivation Protects Against Hepatic Cell Death and Ameliorates Fibrogenesis in a Diet-Induced NASH Model

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Digestive Diseases and Sciences

• Publication date

  2014-05-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10620-014-3167-6PMID 24795036PMCID PMC4512760
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The pan‐caspase inhibitor Emricasan (IDN‐6556) decreases liver injury and fibrosis in a murine model of non‐alcoholic steatohepatitis

  2015cited by this paper
• Hepatocyte caspase‐8 is an essential modulator of steatohepatitis in rodents

  2013cited by this paper
• Caspase-1 as a Central Regulator of High Fat Diet-Induced Non-Alcoholic Steatohepatitis

  2013cited by this paper
• Functional role of intrahepatic monocyte subsets for the progression of liver inflammation and liver fibrosis in vivo

  2012cited by this paper
• Impact of pan-caspase inhibition in animal models of established steatosis and non-alcoholic steatohepatitis.

  2010cited by this paper
• Mechanisms and clinical implications of hepatocyte lipoapoptosis

  2010cited by this paper
• Pan‐caspase inhibitor VX‐166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis

  2009cited by this paper
• Adipocyte Apoptosis, a Link between Obesity, Insulin Resistance, and Hepatic Steatosis*

  2009cited by this paper
• Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis

  2009cited by this paper
• Human Caspases: Activation, Specificity, and Regulation*

  2009cited by this paper
• Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal

  2009cited by this paper
• CCR1 and CCR5 promote hepatic fibrosis in mice.

  2009cited by this paper
• CCR2 promotes hepatic fibrosis in mice

  2009cited by this paper
• Apoptosis and cytokines in non-alcoholic steatohepatitis.

  2009cited by this paper
• Caspases in apoptosis and beyond

  2008cited by this paper
• Diagnosis of Nonalcoholic Fatty Liver Disease: Invasive versus Noninvasive

  2008cited by this paper
• Caspases: structure-guided design of drugs to control cell death.

  2008cited by this paper
• The lysosomal‐mitochondrial axis in free fatty acid–induced hepatic lipotoxicity

  2008cited by this paper
• Caspases - an update.

  2008cited by this paper
• In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease

  2006cited by this paper
• Long‐term follow‐up of patients with NAFLD and elevated liver enzymes

  2006cited by this paper
• Prevalence of Fatty Liver in Children and Adolescents

  2006cited by this paper
• Nonalcoholic fatty liver disease

  2005cited by this paper
• Suppression of macrophage infiltration inhibits activation of hepatic stellate cells and liver fibrogenesis in rats.

  2005cited by this paper
• The natural history of nonalcoholic fatty liver disease: a population-based cohort study.

  2005cited by this paper
• Nonalcoholic fatty liver disease in the pediatric population: a review

  2005cited by this paper
• Apoptosis in alcoholic and nonalcoholic steatohepatitis.

  2005cited by this paper
• Design and validation of a histological scoring system for nonalcoholic fatty liver disease

  2005cited by this paper
• Apoptotic pathways: ten minutes to dead.

  2005cited by this paper
• Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity

  2004cited by this paper
• Steatohepatitis and Apoptosis: Therapeutic Implications

  2004cited by this paper
• Animal models of nonalcoholic fatty liver disease and steatohepatitis.

  2004cited by this paper
• The protein structures that shape caspase activity, specificity, activation and inhibition.

  2004cited by this paper
• Free fatty acids promote hepatic lipotoxicity by stimulating TNF‐α expression via a lysosomal pathway

  2004cited by this paper
• Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis.

  2003cited by this paper
• Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice.

  2003cited by this paper
• Nonalcoholic fatty liver disease.

  2002cited by this paper
• Animal Models of Steatosis

  2001cited by this paper
• Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.

  1999cited by this paper
• Mammalian caspases: structure, activation, substrates, and functions during apoptosis.

  1999cited by this paper
• Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes.

  1998cited by this paper

• Beyond glycemic control: the cardiac and hepatic benefits of SGLT2 and DPP-4 inhibitors in mitigating chronic cadmium-induced inflammation, oxidative/nitrative stress, apoptosis and fibrosis

  2026cites this paper
• Hepatotoxic Effects of Gasoline Fumes in Male Albino Rats: Evidence from Pro-Inflammatory Cytokine Expression and Apoptotic Marker Activation

  2026cites this paper
• Combination of THU/ALK-5i exhibits profound anti-MASH activity through suppression of lipogenesis and fibrogenesis

  2025cites this paper
• Lasting Multiorgan Protective Effect of Stem Cells in Systemic Endotoxaemia

  2025cites this paper
• Caspase-3调控非酒精性脂肪性肝病细胞焦亡和凋亡的研究进展

  2025cites this paper
• Genome-Based Mexican Diet Bioactives Target Molecular Pathways in HBV, HCV, and MASLD: A Bioinformatic Approach for Liver Disease Prevention

  2025cites this paper
• Repositioning Gemigliptin for the Alleviation of Thioacetamide-Induced Liver Fibrosis in Rats: Targeting TLR4/MAPK, SIRT1/AMPK/Nrf2, PI3K/AKT/mTOR Axis and Apoptosis.

  2025cites this paper
• Nano-encapsulated ferulic acid in sesame protein isolate alleviates acrylamide-induced liver toxicity and genotoxicity in rats via oxidative stress and DNA damage modulation

  2025cites this paper
• Pharmacological Evaluation of Araliadiol as a Novel Anti-Inflammatory Agent in LPS-Induced RAW 264.7 Cells

  2025cites this paper
• Integrated profiling of adiponectin and cytokine signaling pathways in high-fat diet-induced MASLD reveals early markers of disease progression

  2025cites this paper
• Towards novel liver injury therapies based on design, synthesis and therapeutic efficacy of novel sulfone bis-compound on liver necrosis

  2025cites this paper
• Exploring the Hepatoprotective Effects of Naringin: A Systematic Review and Meta-Analysis of Preclinical Evidence

  2025cites this paper
• Disruption of Hepatic Sinusoidal Homeostasis Leads to Hepatopulmonary Syndrome

  2025cites this paper
• The impact of leptin receptor (LepR) mutation on the development of MASLD in a murine model.

  2025cites this paper
• Dapagliflozin alleviates thioacetamide induced-liver fibrosis in rats via controlling the Nrf2/HO-1 and TLR4/TGF-β1/PI3K signaling pathways

  2025cites this paper
• Antifibrotic therapies for metabolic dysfunction-associated steatotic liver disease

  2025cites this paper
• Life-threatening risk factors contribute to the development of diseases with the highest mortality through the induction of regulated necrotic cell death

  2025cites this paper
• The Ways to Die: Cell Death in Liver Pathophysiology

  2025cites this paper
• Passion Fruit Seed Extract Attenuates Hepatic Steatosis in Oleic Acid-Treated HepG2 Cells through Modulation of ERK1/2 and Akt Signaling Pathways

  2025cites this paper
• Amyloid precursor protein promotes MASH progression by upregulating death receptor 6–mediated hepatocyte apoptosis

  2025cites this paper
• Impact of Mlkl or Ripk3 deletion on age-associated liver inflammation, metabolic health, and lifespan

  2025cites this paper
• Nicotinamide Adenine Dinucleotide Phosphate Oxidases and Metabolic Dysfunction-Associated Steatotic Liver Disease

  2025cites this paper
• Mesenchymal stem cell and exosome-based therapy for liver diseases: can it overcome conventional therapeutic inconsistencies?

  2025cites this paper
• Validating hepatoprotective potency of caffeic acid targeting BCL-2/Caspase-3 axis against endotoxin-driven liver toxicity: an in vivo and in silico approach

  2025cites this paper
• Exploration of the Pharmacological Mechanism of Herbal Medicines against Hepatic Disorder: A Systematic Review and Network Pharmacological Analysis

  2024cites this paper
• Methyl donor ameliorates CCl4-induced liver fibrosis by inhibiting inflammation, and fibrosis through the downregulation of EGFR and DNMT-1 expression.

  2024cites this paper
• Hypoxia-Inducible Factor-2α Promotes Liver Fibrosis by Inducing Hepatocellular Death

  2024cites this paper
• Computational dissection through network pharmacology and structure-based analysis unravels mechanistic actions of bioactive compounds in a hepatoprotective herb, Picrorhiza kurroa for the treatment of NAFLD and NASH.

  2024cites this paper
• The concealed side of caspases: beyond a killer of cells

  2024cites this paper
• Humanized monoacylglycerol acyltransferase 2 mice develop metabolic dysfunction-associated steatohepatitis

  2024cites this paper
• The liver as a central "hub" of the immune system: pathophysiological implications.

  2024cites this paper
• Emerging mechanisms of non-alcoholic steatohepatitis and novel drug therapies.

  2024cites this paper
• Ultra‐high‐performance liquid chromatography‐quadrupole time‐of‐flight‐mass spectrometry‐characterized extract of Aerides odorata Lour alleviates paracetamol‐induced hepatotoxicity in animal model evidenced by biochemical, molecular, and computational studies

  2024cites this paper
• Potential therapeutic strategies for MASH: from preclinical to clinical development

  2024cites this paper
• Apomorphine Suppresses the Progression of Steatohepatitis by Inhibiting Ferroptosis

  2024cites this paper
• Lack of Nr2e1 expression in hepatocytes impaired cell survival and aggravated palmitate-induced oxidative stress.

  2024cites this paper
• A model of alcoholic liver disease based on different hepatotoxics leading to liver cancer.

  2024cites this paper
• Ex-vivo expanded CD34+ cell transplantation alleviates fibrotic liver injury via innate immune modulation in metabolic dysfunction-associated steatohepatitis mice.

  2024cites this paper
• Emerging role of ferroptosis in metabolic dysfunction-associated steatotic liver disease: revisiting hepatic lipid peroxidation

  2024cites this paper
• Cell Death in Liver Disease and Liver Surgery

  2024cites this paper
• Serum level of proteins involved in apoptosis and autophagy in patients with type 2 diabetes and non-alcoholic fatty liver disease

  2024cites this paper
• Combinatorial Therapeutic Potential of Stem Cells and Benzimidazol Derivatives for the Reduction of Liver Fibrosis

  2023cites this paper
• Regulation of protein O-GlcNAcylation by circadian, metabolic, and cellular signals

  2023cites this paper
• Combined quercetin and simvastatin attenuate hepatic fibrosis in rats by modulating SphK1/NLRP3 pathways.

  2023cites this paper
• Neonatal nicotine exposure affects adult rat hepatic pathways involved in endoplasmic reticulum stress and macroautophagy in a sex-dependent manner

  2023cites this paper
• Current investigations for liver fibrosis treatment: between repurposing the FDA-approved drugs and the other emerging approaches

  2023cites this paper
• CD1d protects against hepatocyte apoptosis in non-alcoholic steatohepatitis.

  2023cites this paper
• Every-other day (EOD) feeding regime decreases oxidative stress and inflammatory cascade in mouse liver: The immunohistochemical study.

  2023cites this paper
• Indole-3-carbinol and chlorogenic acid combination modulates gut microbiome and attenuates nonalcoholic steatohepatitis in a murine model.

  2023cites this paper
• Immunohistochemical expression of NRF2 is correlated with the magnitude of inflammation and fibrosis in chronic liver disease

  2023cites this paper
• Glabridin ameliorates intracellular events caused by palmitic acid and alcohol in mouse hepatocytes and fast food diet and alcohol -induced steatohepatitis and fibrosis in C57BL/6J mice model.

  2023cites this paper
• Mechanisms of liver fibrosis in metabolic syndrome

  2023cites this paper
• Based on the Pharmacology and Molecular Docking of Traditional Chinese Medicine Network, the Components and Mechanism of Action of Safflower in the Prevention and Treatment of Liver Fibrosis Were Studied

  2023cites this paper
• Therapeutic inhibition of miR-155 attenuates liver fibrosis via STAT3 signaling

  2023cites this paper
• Exploring the mechanism of Cassiae semen in regulating lipid metabolism through network pharmacology and experimental validation

  2023cites this paper
• Gluten worsens non-alcoholic fatty liver disease by affecting lipogenesis and fatty acid oxidation in diet-induced obese apolipoprotein E-deficient mice

  2023cites this paper
• SGLT-2 Inhibitors for Non-Alcoholic Fatty Liver Disease: A Review.

  2023cites this paper
• BAG6 is a novel player in controlling nonalcoholic steatohepatitis: result from a comprehensive in-silico study

  2023cites this paper
• Apoptotic cell death in disease—Current understanding of the NCCD 2023

  2023cites this paper
• Lentinan Protects against Nonalcoholic Fatty Liver Disease by Reducing Oxidative Stress and Apoptosis via the PPARα Pathway

  2022cites this paper
• Stearoyl-CoA desaturase 1: A potential target for non-alcoholic fatty liver disease?-perspective on emerging experimental evidence

  2022cites this paper
• Programmed cell death and liver diseases

  2022cites this paper
• Sex-Dependent Hepatoprotective Role of IL-22 Receptor Signaling in Non-Alcoholic Fatty Liver Disease-Related Fibrosis

  2022cites this paper
• Tanshinone IIA Ameliorates Nonalcoholic Steatohepatitis in Mice by Modulating Neutrophil Extracellular Traps and Hepatocyte Apoptosis

  2022cites this paper
• Active Compounds Screening and Hepatoprotective Mechanism of Shuganning Injection Based on Network Pharmacology and Experimental Validation

  2022cites this paper
• Role of Oxidative Stress in Liver Disorders

  2022cites this paper
• Study on the Mechanism of Zhenwu Decoction in Decreasing the Fats in Non-Alcoholic Fatty Liver Disease Using System Pharmacology and Cytological Validation Test

  2022cites this paper
• Mechanisms of Cynarine for treatment of non-alcoholic fatty liver disease based on the integration of network pharmacology, molecular docking and cell experiment

  2022cites this paper
• HES5-mediated repression of LIGHT transcription may contribute to apoptosis in hepatocytes

  2021cites this paper
• HES5-mediated repression of LIGHT transcription may contribute to apoptosis in hepatocytes

  2021cites this paper
• Selenium enriched yeast and Gum Arabic combination attenuate oxidative liver damage via suppression of oxidative stress, inhibition of caspase-3 and pro-inflammatory genes expression in carbon tetrachloride-intoxicated rats

  2021cites this paper
• Efficacy and Safety of Emricasan in Liver Cirrhosis and/or Fibrosis

  2021cites this paper
• Protective role of Saikosaponin d in d-galactosamine and lipopolysaccharide-induced liver injury in hybrid grouper (Epinephelus lanceolatus♂ × Epinephelus fuscoguttatus♀)

  2021cites this paper
• Intravenous Injection of Umbilical Cord-Derived Mesenchymal Stem Cells Improved Regeneration of Rat Liver after 2AAF/CCl4-Induced Injury

  2021cites this paper
• Hyoscyamus albus nortropane alkaloids reduce hyperglycemia and hyperinsulinemia induced in HepG2 cells through the regulation of SIRT1/NF-kB/JNK pathway

  2021cites this paper
• Effects of high fructose diet on lipid metabolism and the hepatic NF-κB/ SIRT-1 pathway

  2021cites this paper
• Hepatocyte and immune cell crosstalk in non-alcoholic fatty liver disease

  2021cites this paper
• Splenectomy Prior to Experimental Induction of Autoimmune Hepatitis Promotes More Severe Hepatic Inflammation, Production of IL-17 and Apoptosis

  2021cites this paper
• Sulforaphane Attenuates Nonalcoholic Fatty Liver Disease by Inhibiting Hepatic Steatosis and Apoptosis

  2021cites this paper
• The Metabolic Sensor AMKP Regulates Apoptosis in NASH.

  2020cites this paper
• Benzyl isothiocyanate ameliorates high-fat/cholesterol/cholic acid diet-induced nonalcoholic steatohepatitis through inhibiting cholesterol crystal-activated NLRP3 inflammasome in Kupffer cells.

  2020cites this paper
• Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives

  2020cites this paper
• A Trans Fatty Acid Substitute Aggravates Nonalcoholic Steatohepatitis Induced in Mice by Feeding a Choline-De cient, Methionine-Lowered, L- Amino Acid-De ned, High-Fat Diet

  2020cites this paper
• Les mécanismes de mort cellulaire dans la stéatohépatite non alcoolique

  2020cites this paper
• Cell Death in Liver Diseases: A Review

  2020cites this paper
• Anti-fibrotic treatments for chronic liver diseases: The present and the future

  2020cites this paper
• A trans fatty acid substitute enhanced development of liver proliferative lesions induced in mice by feeding a choline-deficient, methionine-lowered, L-amino acid-defined, high-fat diet

  2020cites this paper
• The Metabolic Sensor Adenosine Monophosphate–Activated Protein Kinase Regulates Apoptosis in Nonalcoholic Steatohepatitis

  2020cites this paper
• Anti-inflammatory and anti-oxidant effects of aloe vera in rats with non-alcoholic steatohepatitis

  2020cites this paper
• [Cell death mechanisms in non-alcoholic steatohepatitis].

  2020cites this paper
• An AMPK–caspase-6 axis controls liver damage in nonalcoholic steatohepatitis

  2020cites this paper
• Mechanisms of Fibrosis Development in NASH.

  2020cites this paper
• A randomized, placebo-controlled trial of emricasan in patients with NASH and F1-F3 fibrosis.

  2019cites this paper
• Processes exacerbating apoptosis in non-alcoholic steatohepatitis.

  2019cites this paper
• Soc . Physiol . Sci . 39 ( 2 ) , 173-190 Possible Role of Angiogenesis Suppression in Rats Model of Non-alcoholic Fatty Liver Disease

  2019cites this paper
• Targeting AngII/AT1R signaling pathway by perindopril inhibits ongoing liver fibrosis in rat

  2019cites this paper
• Cell death in drug-induced liver injury.

  2019cites this paper
• Decrease in fat de novo synthesis and chemokine ligand expression in non‐alcoholic fatty liver disease caused by inhibition of mixed lineage kinase domain‐like pseudokinase

  2019cites this paper
• Zoledronic acid prevents the hepatic changes associated with high fat diet in rats; the potential role of mevalonic acid pathway in nonalcoholic steatohepatitis.

  2019cites this paper
• Hepatic ferroptosis plays an important role as the trigger for initiating inflammation in nonalcoholic steatohepatitis

  2019cites this paper